Drug Name: Xacduro
Indications: To treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex.
Active Ingredient: Sulbactam, Durlobactam
Company: Entasis Therapeutics Ltd
Approval Date: 5/23/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216974Orig1s000Correctedlbl.pdf